Publications
Assessing the efficacy of an integrated intervention to create demand for fishermen’s schistosomiasis and HIV services (FISH) in Mangochi, Malawi: Study protocol for a cluster randomized control trial.
Conserve DF, Kayuni S, Kumwenda MK, Dovel KL, Choko AT,
- January 1, 2022
Same-day antiretroviral therapy initiation for people living with HIV who have tuberculosis symptoms: a systematic review.
Burke RM, Rickman HM, Singh V, Kalua T, Labhardt ND, Hosseinipour M, Wilkinson RJ, MacPherson P,
- January 1, 2022
Know your tuberculosis epidemic-Is it time to add Mycobacterium tuberculosis immunoreactivity back into global surveillance?
Rickman HM, Kamchedzera W, Schwalb A, Phiri MD, Ruhwald M, Shanaube K, Dodd PJ, Houben RMGJ, Corbett EL, MacPherson P,
- January 1, 2022
A network of empirical ethics teams embedded in research programmes across multiple sites: opportunities and challenges in contributing to COVID-19 research and responses.
Ngwenya N, Ilo Van Nuil J, Nyirenda D, Chambers M, Cheah PY, Seeley J, Chi P, Mafuleka L, Nkosi B, Kamuya D, Davies A, Schneiders ML, Mumba N, Dlamini S, Desmond N, Marsh V, Rippon D, Parker M, Molyneux S,
- January 1, 2022
Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi.
Nyirenda-Nyang’wa M, Manthalu G, Arnold M, Nkhoma D, Hosseinipour MC, Chagomerana M, Chibwe P, Mortimer K, Kennedy N, Fairley D, Mwapasa V, Msefula C, Mwandumba HC, Chinkhumba J, Klein N, Alber D, Obasi A,
- January 1, 2022
Drivers of Resistance in Uganda and Malawi (DRUM): a protocol for the evaluation of One-Health drivers of Extended Spectrum Beta Lactamase (ESBL) resistance in Low-Middle Income Countries (LMICs).
Cocker D, Sammarro M, Chidziwisano K, Elviss N, Jacob ST, Kajumbula H, Mugisha L, Musoke D, Musicha P, Roberts AP, Rowlingson B, Singer AC, Byrne RL, Edwards T, Lester R, Wilson CN, Hollihead B, Thomson NR, Jewell CP, Morse T, Feasey NA,
- January 1, 2022
Cost of wastewater-based environmental surveillance for SARS-CoV-2: Evidence from pilot sites in Blantyre, Malawi and Kathmandu, Nepal.
Ngwira LG, Sharma B, Shrestha KB, Dahal S, Tuladhar R, Manthalu G, Chilima B, Ganizani A, Rigby J, Kanjerwa O, Barnes K, Anscombe C, Mfutso-Bengo J, Feasey N, Mvundura M,
- January 1, 2022